Hims & Hers Health Inc - Class A risk profile
62 Stretched several inputs deteriorating together
Measured 21 October 2026 from HIMS's filed statements. Recomputed nightly.
62 (Stretched), driven by Concentration at 93, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 72 | Stretched | Volatile | One-year price volatility — 88.7% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 39 | Normal | Worsening | Capital spending against operating cash — 0.81x |
| Leverage and coverage | 63 | Stretched | Worsening | Net debt to EBITDA — 5.57x |
| Competitive position | 45 | Elevated | Stable | Operating-margin gap against peers — -3.0 percentage points |
| Concentration | 93 | Acute | Stable | Geographic concentration — 8,891 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Hims & Hers Health Inc - Class A